CONTROLLED MEDICATION DENATURING COMPOSITION AND METHOD
In one aspect, a composition for decomposing pharmaceutically active agents comprises an oxidizer comprising a permanganate, and an isocyanurate; and an immobilizer. In another aspect, a composition comprises up to 50 wt. % of an oxidizer comprising potassium permanganate and sodium dichloroisocyanurate dehydrate, wherein the wt. % is based on a total weight of the composition.
1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . (canceled)
14 . (canceled)
15 . (canceled)
16 . A method of degrading a pharmaceutically active ingredient, comprising:
placing the pharmaceutically active ingredient in the composition of claim 1 ; and
degrading the pharmaceutically active ingredient.
17 . The method of claim 16 , wherein the pharmaceutically active ingredient is a US Drug Enforcement Agency identified schedule I, II, III, IV, and/or V controlled substance.
18 . The method of claim 16 , wherein degrading the pharmaceutically active ingredient comprising rendering the pharmaceutically active ingredient non-retrievable as defined by the US Drug Enforcement Agency under 21 C.F.R. § 1300.05.
19 . The method of claim 16 , further comprising adding water to the composition of claim 1 .
20 . The method of claim 16 , wherein the pharmaceutically active ingredient is degraded within two hours after being placed in the composition of claim 1 .